# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Market Perform and raises the price target from $50 t...
Loop Capital analyst Christopher Kapsch maintains Ingevity (NYSE:NGVT) with a Hold and raises the price target from $49 to $56.
Oppenheimer analyst Ian Zaffino maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $50 to $58.
Ingevity (NYSE:NGVT) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.32 by 62.5 ...
Jefferies analyst Daniel Rizzo upgrades Ingevity (NYSE:NGVT) from Hold to Buy and raises the price target from $52 to $62.